Founded by neuroscientists Iftach Dolev, PhD, and Hilla Fogel, PhD, QuantalX develops neurodiagnostic technology that measures brain-network function in real time. Its Delphi-MD system combines focused magnetic stimulation, electrophysiological recording, and algorithmic analysis to give clinicians quantitative functional insights alongside conventional evaluation. The FDA De Novo-authorized platform is used in clinics and research sites across Europe, Asia, and North America.
FDA De Novo Authorization for Delphi-MD™
Neurosteer IncFounded in 2015 by Tel Aviv University professor Nathan Intrator, Neurosteer develops a wearable, medical-grade brain-activity interpretation platform built around a pocket-sized, single-channel EEG monitor. Its wireless forehead sensor and cloud-based analysis provide real-time brain metrics for clinical assessment, continuous monitoring and research, and the device has FDA Class II clearance. Neurosteer’s teams work across New York, California and Israel, drawing on expertise in neuroscience and signal processing.NEW YORK, NY
BrainScope Company, IncFounded in 2006, BrainScope develops medical neurotechnology that converts brain electrical activity (EEG) into objective, point-of-care assessments for brain health. Its FDA-cleared system was the first AI/machine-learning medical device cleared in neurology and is used to assess head injuries for the likelihood of brain bleeds and concussion without radiation. The company is now extending its EEG-based platform into digital biomarkers for conditions including stroke and cognitive decline.ROCKVILLE, MD
Firefly Neuroscience, IncFirefly Neuroscience is a healthcare technology company focused on bringing direct measurement of brain function into routine clinical care. Its FDA-cleared Evoke™ system helps clinicians interpret brain activity alongside clinical evaluation, giving providers a clearer basis for decisions involving neurological and behavioral conditions.BUFFALO, NY
QDSENSEAs a Morgan State University spin-out founded by Dr. Birol Ozturk, QDSENSE develops compact NV-diamond quantum sensors for portable magnetic-field measurement and brain imaging. Its CQS devices are battery-operated prototypes for field use, while the DMEG platform uses room-temperature diamond sensing to pursue practical, scalable detection of brain signals without cryogenic cooling. The company combines optically detected magnetic resonance with machine-learning inference to extract vector field information from compact devices.COLUMBIA, MD